Bookmark and Share
ramatroban (CID 123879) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(34)
 
 
Inactive(177)
 
 
Inconclusive(9)
 
 
Unspecified(20)
 
 
Top Targets:
NR LBD PPAR(8)
 
 
 
NR LBD AR(7)
 
 
NR LBD ER(7)
 
 
p450(6)
 
 
 
 
NR LBD VDR(5)
 
 
 
BioAssay Types:
Literature(111)
 
 
 
 
 
Confirmatory(103)
 
 
 
 
Summary(24)
 
 
 
Screening(2)
 
 
BioActivity Types:
Potency(120)
 
 
 
 
IC50(23)
 
 
 
 
Ki(11)
 
 
 
Kd(1)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 176    Data Row: 240   Total Pages: 5   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103444835]
Ki 0.00058Binding affinity to thromboxane receptor [AID551275, Type: Literature]
View
2
[SID103444835]
Ki 0.0043Inhibition of [3H]PGD-2 binding to human chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) [AID239567, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
3
[SID103444835]
Ki 0.0045Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor [AID238927, Type: Literature]Thromboxane A2 receptor [gi:229463010]
View
4
[SID103444835]
IC50 0.0084Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay [AID248580, Type: Literature]Thromboxane A2 receptor [gi:229463010]
View
5
[SID103444835]
IC50 0.0096Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor [AID248754, Type: Literature]Thromboxane A2 receptor [gi:229463010]
View
6
[SID144206069]
Potency 0.0103qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Counterscreen HTRF assay [AID651843, Type: confirmatory]histone-lysine N-methyltransferase 2A isoform 2 precursor [Homo sapiens] [gi:56550039]
View
7
[SID144206069]
Potency 0.0103qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Counterscreen HTRF assay [AID651843, Type: confirmatory]menin isoform 1 [Homo sapiens] [gi:18860839]
View
8
[SID50112772]
Potency 0.0116qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation in AlphaScreen assay for MBNL1-(CUG)12 binding [AID493205, Type: confirmatory]muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591]
View
9
[SID103444835]
Kd 0.01259Compound was tested for inhibition of U-46,619 induced contraction of isolated rabbit saphenous vein [AID166818, Type: Literature]
View
10
[SID103444835]
IC50 0.014Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane [AID429618, Type: Literature]Thromboxane A2 receptor [gi:229463010]
View
11
[SID50112772]
Potency 0.0163qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding: Initial hit validation from the primary screen [AID493199, Type: confirmatory]muscleblind-like protein 1 isoform a [Homo sapiens] [gi:41281591]
View
12
[SID103444835]
Ki 0.018Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes [AID244585, Type: Literature]
View
13
[SID103444835]
IC50 0.021Antagonist activity against CRTh2 receptor in human eosinophils assessed as cell shape change [AID431338, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
14
[SID103444835]
IC50 0.028Inhibition of beta-arrestin translocation at human chemoattractant receptor-homologous molecule expressed on TH2 cells in BRET assay [AID248959, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
15
[SID103444835]
IC50 0.029Inhibition of PGD2-induced inositol phosphate formation at human chemoattractant receptor-homologous molecule expressed on TH2 cells [AID248926, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
16
[SID103444835]
IC50 0.05Anti-platelet activity was measured by studying their antagonist effects on human platelets aggregated with collagen [AID92808, Type: Literature]
View
17
[SID103444835]
Ki 0.073Displacement of [3H]PGD2 from human CRTh2 receptor expressed in CHO cells [AID431337, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
18
[SID103444835]
IC50 0.077Displacement of [3H]PGD2 from human CRTh2 receptor expressed in HEK293 cells after 2 hrs by scintillation proximity assay [AID586985, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
19
[SID103444835]
Ki 0.137Binding affinity to human recombinant CRTH2 receptor by cell based radioligand equilibrium competition assay [AID551273, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
20
[SID103444835]
IC50 0.169Antagonist activity at human CRTH2 receptor assessed as inhibition of DK-PGD2-induced eosinophil chemotaxis [AID330825, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
21
[SID103444835]
IC50 0.195Antagonist activity against CRTh2 receptor in human whole blood assessed as eosinophil shape change [AID431356, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
22
[SID103444835]
IC50 0.21Antagonist activity against human CRTh2 receptor expressed in CHO cells assessed as effect on cAMP accumulation [AID431354, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
23
[SID103444835]
Ki 0.29Inhibitory activity for binding of PGD-2 to CRTH-2 in hCRTH-2 binding assay using HEK293 cell membranes [AID244593, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
24
[SID103444835]
Ki 0.29Inhibitory activity for PGD2-mediated receptor activation in a fluorescence assay that measures changes in intracellular calcium [AID244599, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
25
[SID103444835]
IC50 0.311Displacement of [3H]PGD2 from human prostaglandin D2 receptor [AID429614, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
26
[SID103444835]
Ki 0.34Inhibitory concentration for PGD2-mediated receptor activation in a fluorescence assay that measures changes in intracellular calcium [AID244604, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
27
[SID103444835]
IC50 0.38Compound was tested for inhibition of U-46,619 induced aggregation of human platelets [AID92098, Type: Literature]
View
28
[SID103444835]
IC50 0.461Antagonist activity against human CRTh2 receptor expressed in CHO cells assessed as inhibition of PGD2-mediated Ca2+ flux [AID586990, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
29
[SID103444835]
IC50 0.754Displacement of [3H]PGD2 from human prostaglandin D2 receptor in presence of human serum albumin [AID429615, Type: Literature]Prostaglandin D2 receptor 2 [gi:296439334]
View
30
[SID103444835]
IC50 1.21Inhibition of eosinophil degranulation in human whole blood assessed as change in morphology after 4 mins using flow cytometry by leukocyte shape change assay [AID429616, Type: Literature]
View
31
[SID103444835]
Ki 11.02Binding affinity to prostanoid DP1 receptor [AID551274, Type: Literature]
View
32
[SID103444835]
IC50 15Inhibition of human CYP2C9 [AID429621, Type: Literature]Cytochrome P450 2C9 [gi:6686268]
View
33
[SID103444835]
IC50 33.4Displacement of [3H]PGD2 from prostaglandin D1 receptor in human platelet membrane [AID429617, Type: Literature]Prostaglandin D2 receptor [gi:2495009]
View
34
[SID50112772]
Potency S16 Schwann cell PMP22 intronic element beta-lactamase assay [AID624044, Type: confirmatory]peripheral myelin protein 22 [Rattus norvegicus] [gi:8393992]
View
35
[SID103444835]
IC50 10Inhibition of PGD2-induced inositol phosphate formation at human Prostaglandin D2 receptor [AID248439, Type: Literature]Prostaglandin D2 receptor [gi:2495009]
View
36
[SID103444835]
Ki 10Inhibition of [3H]-PGD-2 binding to human Prostaglandin D2 receptor [AID238910, Type: Literature]Prostaglandin D2 receptor [gi:2495009]
View
37
[SID103444835]
IC50 30Inhibition of human CYP2D6 [AID429622, Type: Literature]Cytochrome P450 2D6 [gi:84028191]
View
38
[SID103444835]
IC50 30Inhibition of human CYP3A4 [AID429620, Type: Literature]Cytochrome P450 3A4 [gi:116241312]
View
39
[SID103444835]
IC50 100Displacement of [3H]iloprost from human prostacyclin receptor expressed in human 293 cell membrane [AID429619, Type: Literature]Prostacyclin receptor [gi:1172500]
View
40
[SID103444835]
Inhibition of human H-PGDS expressed in Escherichia coli BL21 assessed as rate of glutathione-chloro-dinitro benzene conjugation at 50 uM [AID442515, Type: Literature]Hematopoietic prostaglandin D synthase [gi:6225843]
View
41
[SID103444835]
Toxicity in human liver microsomes assessed as GSH adduct formation in presence of NADPH and glutathione [AID429624, Type: Literature]
View
42
[SID103444835]
Protein binding in human plasma by HSA column HPLC method [AID431357, Type: Literature]
View
43
[SID103444835]
Compound was tested for inhibition of U-46,619 induced increase in tracheal pressure of guinea pigs [AID76697, Type: Literature]
View
44
[SID103444835]
Anti-platelet activity was measured by studying their antagonist effects on rabbit platelets aggregated with U-46,619.; NT means not tested. [AID165613, Type: Literature]
View
45
[SID103444835]
Lipophilicity, log D of the compound at pH 7.4 [AID586986, Type: Literature]
View
46
[SID103444835]
Lipophilicity, log P of the compound [AID598525, Type: Literature]
View
47
[SID103444835]
1-Octanol-water distribution coefficient, log D of the compound at pH 7.4 by shake-flask method [AID598526, Type: Literature]
View
48
[SID103444835]
1-Octanol-sodium citrate buffer distribution coefficient, log D of the compound at pH 5.5 by shake-flask method [AID598527, Type: Literature]
View
49
[SID103444835]
Plasma protein binding in human [AID599064, Type: Literature]
View
50
[SID50112772]
qHTS profiling for inhibitors of Plasmodium falciparum proliferation [AID504749, Type: Literature]
View